Brief: Renovorx Reports First Quarter 2023 Financial Results And Operational Highlights
15/05/2023 13:36
RenovoRx Inc RNXT.O :
* RENOVORX REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
OPERATIONAL HIGHLIGHTS
* RENOVORX INC - CASH AND CASH EQUIVALENTS AS OF MARCH 31,
2023,
WERE $3.7 MILLION
Source text for Eikon: ID:nBw8d7qPja
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer